Share

    


Home / Search Results

Search Results

Search Publications

Search Again?

Filter By Content Type

Filter By Topic

You searched for:

Attend this free e-course to learn more about clinical trials as a treatment option for patients with blood cancer. Kelly Laschinger, MSN, RN, CPNP, CPHON, manager of the Leukemia & Lymphoma Society’s (LLS’s) Clinical Trial Support Center (CTSC) in Rye Brook, New York, and Steven Tsai, MD, PhD, hematologist at UCLA Health Cancer Care in Los Angeles, California, will discuss the CTSC created by …
One serious, unwanted side effect of the COVID-19 pandemic is the potential for substantial consequences for cancer outcomes due to delayed access to cancer diagnosis and treatment. Hear from Dr. Debra Patt, the author of a study which detected a substantial decrease (among American seniors) in cancer screenings, visits, therapy, and surgeries.
Insight from 2 ACCC members on the implementation of the Improving Care Coordination Model.
A comparison between the Enhancing Oncology Model (EOM), and its predecessor, the Oncology Care Mode (OCM).
Hear from ACCC 2021-2022 President, Krista Nelson, MSW, LCSW, OSW-C, FAOSW, as she talks about two new resources (a business case brief for hiring and a benchmarking survey) coming from ACCC that demonstrate the value oncology social workers play in cancer care.
Radiofrequency Thermal Ablation as Tumor Therapy: An Overview for the Oncology Team Radiofrequency Thermal Ablation as Tumor therapy: An Overview for the Oncology Team by Bradford J. Wood, M.D., and Mary T. Wink ler ecen r develop. ments in rediofrequency thermal able- tion (RFA) haveexpanded the treatment options for cer- tain onco logy patients. Minimally invasive. image- guided therapy …
While not yet mainstream in the community setting, hear how measurable residual disease (MRD) testing has the potential to become more fully integrated into clinical practice as one of the reliable markers of treatment response for patients with multiple myeloma and chronic lymphocytic leukemia.
An Optimal Care Coordination Model (OCCM) for Medicaid Patients With Lung Cancer: Finalization of the Model and Implications for Clinical Practice in the United States Randall A. Oyer1; Christopher S. Lathan2,3; Matthew P. Smeltzer4; Amanda Kramar5; Leigh M. Boehmer5; Thomas M. Asfeldt6,7 1Ann B. Barshinger Cancer Institute, Penn Medicine Lancaster General Health, Lancaster, PA, USA; 2Dana-Farber …
ACCC will develop a provider survey to identify current practice patterns regarding treatment selection, guideline-based management of adverse events, care coordination within the care team, patient education, prior authorization, and barriers to patients
Andre Harvin teases his keynote at the ACCC 49th Annual Meeting and Cancer Center Business Summit, where he will talk about innovative solutions to streamline pharmacy operations that have saved his healthcare system millions of dollars. One of those innovative solutions—robotic pharmacists.
In this episode, CANCER BUZZ TV speaks with Tom Lycan, DO, MHS, assistant professor of Hematology & Oncology at the Wake Forest School of Medicine, about a practical tool that can provide a care plan roadmap for providers and patients to mitigate precision medicine disparities.
As myeloproliferative neoplasms (MPNs) carry a significant symptom burden and oftentimes can require lifelong care coordination and close monitoring, hear how a strong multidisciplinary approach can impact shared decision-making and patient engagement.
Advancements in clinical data and research have shown the immunotherapeutic potential of bispecific antibodies as treatment for hematologic cancers and solid tumors. In this episode, CANCER BUZZ speaks with Aaron Cumpston, PharmD, pharmacy clinical specialist in hematologic malignancies and bone marrow transplant and Christine Barrett, PharmD, BCOP, medical oncology clinical pharmacy specialist at …
Networks, Markets, and Cost Control in the Age of Health Care Reform Full Terms & Conditions of access and use can be found at https://www.tandfonline.com/action/journalInformation?journalCode=uacc20 Oncology Issues ISSN: 1046-3356 (Print) 2573-1777 (Online) Journal homepage: https://www.tandfonline.com/loi/uacc20 Networks, Markets, and Cost Control in the Age of Health Care Reform …
Clinical Trial Highlights from the 21st Annual San Antonio Breast Cancer Symposium Full Terms & Conditions of access and use can be found at https://www.tandfonline.com/action/journalInformation?journalCode=uacc20 Oncology Issues ISSN: 1046-3356 (Print) 2573-1777 (Online) Journal homepage: https://www.tandfonline.com/loi/uacc20 Clinical Trial Highlights from the 21st Annual San Antonio …
The aim of this project is to reframe the conversation between patients and providers to incorporate new therapy advancements, set expectations with patients about their treatment journey, and give them more confidence that there is new hope.
Overexpression or amplification of the human epidermal growth factor receptor 2 (HER2) is present in approximately 15 percent to 20 percent of patients with metastatic breast cancer. First-line therapy with anti-HER2 targeted agents have significantly improved outcomes for patients with HER2-positive breast cancer. Nevertheless, most of these patients eventually relapse. Several novel therapies have …
FAN-Development-of-a-Financial-Toxicity-Patient-Reported-Outcome-in-Cancer